Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""ANASTROZOLE"" wg kryterium: Temat


Tytuł:
A case report of cystoid macular edema, uveitis and vitreomacular traction in a patient taking Anastrozole
Autorzy:
Kevin H. Nguyen
Andrew K. Smith
Brian T. Kim
Andrew W. Browne
Pokaż więcej
Temat:
Anastrozole
Cystoid macular edema
Uveitis
Vitreomacular traction
Breast cancer
Ophthalmology
RE1-994
Źródło:
American Journal of Ophthalmology Case Reports, Vol 25, Iss , Pp 101339- (2022)
Opis pliku:
electronic resource
Relacje:
http://www.sciencedirect.com/science/article/pii/S2451993622000858; https://doaj.org/toc/2451-9936
Dostęp URL:
https://doaj.org/article/df99837d5d5a470fad062ad92cedef1d  Link otwiera się w nowym oknie
Czasopismo naukowe
Tytuł:
Aromatase inhibitors for female infertility: a systematic review of the literature.
Autorzy:
Polyzos NP; PACMeR (PanHellenic Association for Continual Medical Research), Section of Obstetrics and Gynaecology and Public Health, Athens 10438, Greece. />Tzioras S
Badawy AM
Valachis A
Dritsas C
Mauri D
Pokaż więcej
Źródło:
Reproductive biomedicine online [Reprod Biomed Online] 2009 Oct; Vol. 19 (4), pp. 456-71.
Typ publikacji:
Journal Article; Review; Systematic Review
MeSH Terms:
Aromatase Inhibitors/*therapeutic use
Gonadotropins/*therapeutic use
Infertility, Female/*drug therapy
Ovulation Induction/*methods
Adult ; Anastrozole ; Aromatase Inhibitors/administration & dosage ; Clomiphene/therapeutic use ; Female ; Fertilization in Vitro ; Humans ; Infant, Newborn ; Letrozole ; Nitriles/therapeutic use ; Polycystic Ovary Syndrome/drug therapy ; Pregnancy ; Pregnancy Rate ; Randomized Controlled Trials as Topic ; Triazoles/therapeutic use
Czasopismo naukowe
Tytuł:
Adjuvant aromatase inhibitors for breast cancer.
Autorzy:
Howell A; CRUK Department of Medical Oncology, Christie Hospital NHS Trust, Manchester, M20 4BX, UK.
Pokaż więcej
Źródło:
Lancet (London, England) [Lancet] 2005 Aug 6-12; Vol. 366 (9484), pp. 431-3.
Typ publikacji:
Journal Article; Comment
MeSH Terms:
Antineoplastic Agents, Hormonal/*therapeutic use
Aromatase Inhibitors/*therapeutic use
Breast Neoplasms/*drug therapy
Nitriles/*therapeutic use
Triazoles/*therapeutic use
Anastrozole ; Chemotherapy, Adjuvant ; Female ; Humans ; Middle Aged ; Tamoxifen/therapeutic use
Czasopismo naukowe
Tytuł:
Switching of postmenopausal women with endocrine-responsive early breast cancer to anastrozole after 2 years' adjuvant tamoxifen: combined results of ABCSG trial 8 and ARNO 95 trial.
Autorzy:
Jakesz R; Austrian Breast and Colorectal Cancer Study Group (ABCSG), Vienna Medical University, Vienna General Hospital, Waehringer Guertel 18-20, Vienna A-1090, Austria. />Jonat W
Gnant M
Mittlboeck M
Greil R
Tausch C
Hilfrich J
Kwasny W
Menzel C
Samonigg H
Seifert M
Gademann G
Kaufmann M
Wolfgang J
Pokaż więcej
Corporate Authors:
ABCSG and the GABG
Źródło:
Lancet (London, England) [Lancet] 2005 Aug 6-12; Vol. 366 (9484), pp. 455-62.
Typ publikacji:
Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms:
Antineoplastic Agents, Hormonal/*therapeutic use
Aromatase Inhibitors/*therapeutic use
Breast Neoplasms/*drug therapy
Nitriles/*therapeutic use
Tamoxifen/*therapeutic use
Triazoles/*therapeutic use
Aged ; Anastrozole ; Antineoplastic Agents, Hormonal/adverse effects ; Aromatase Inhibitors/adverse effects ; Breast Neoplasms/metabolism ; Breast Neoplasms/mortality ; Breast Neoplasms/pathology ; Disease Progression ; Disease-Free Survival ; Female ; Humans ; Nitriles/adverse effects ; Postmenopause ; Prospective Studies ; Randomized Controlled Trials as Topic ; Receptors, Estrogen/analysis ; Tamoxifen/adverse effects ; Triazoles/adverse effects
Czasopismo naukowe
Tytuł:
Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer.
Autorzy:
Howell A; Christie Hospital, Manchester, UK. />Cuzick J
Baum M
Buzdar A
Dowsett M
Forbes JF
Hoctin-Boes G
Houghton J
Locker GY
Tobias JS
Pokaż więcej
Corporate Authors:
ATAC Trialists' Group
Źródło:
Lancet (London, England) [Lancet] 2005 Jan 1-7; Vol. 365 (9453), pp. 60-2.
Typ publikacji:
Comparative Study; Journal Article
MeSH Terms:
Antineoplastic Agents, Hormonal/*therapeutic use
Aromatase Inhibitors/*therapeutic use
Breast Neoplasms/*drug therapy
Estrogen Antagonists/*therapeutic use
Nitriles/*therapeutic use
Tamoxifen/*therapeutic use
Triazoles/*therapeutic use
Anastrozole ; Antineoplastic Agents, Hormonal/administration & dosage ; Antineoplastic Agents, Hormonal/adverse effects ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Aromatase Inhibitors/administration & dosage ; Aromatase Inhibitors/adverse effects ; Breast Neoplasms/mortality ; Breast Neoplasms/pathology ; Chemotherapy, Adjuvant ; Disease-Free Survival ; Estrogen Antagonists/administration & dosage ; Estrogen Antagonists/adverse effects ; Female ; Follow-Up Studies ; Humans ; Neoplasm Metastasis ; Neoplasm Recurrence, Local ; Nitriles/administration & dosage ; Nitriles/adverse effects ; Postmenopause ; Randomized Controlled Trials as Topic ; Survival Rate ; Tamoxifen/administration & dosage ; Tamoxifen/adverse effects ; Triazoles/administration & dosage ; Triazoles/adverse effects
Czasopismo naukowe
Tytuł:
Questions about anastrozole for early breast cancer.
Autorzy:
Stasi R
Terzoli E
Pokaż więcej
Źródło:
Lancet (London, England) [Lancet] 2002 Dec 07; Vol. 360 (9348), pp. 1890; author reply 1890-1.
Typ publikacji:
Letter; Comment
MeSH Terms:
Antineoplastic Agents, Hormonal/*therapeutic use
Breast Neoplasms/*drug therapy
Nitriles/*therapeutic use
Triazoles/*therapeutic use
Anastrozole ; Clinical Trials as Topic ; Disease Progression ; Female ; Humans
Opinia redakcyjna
Tytuł:
Questions about anastrozole for early breast cancer.
Autorzy:
Thornton H
Pokaż więcej
Źródło:
Lancet (London, England) [Lancet] 2002 Dec 07; Vol. 360 (9348), pp. 1890; author reply 1890-1.
Typ publikacji:
Letter; Comment
MeSH Terms:
Antineoplastic Agents, Hormonal/*therapeutic use
Breast Neoplasms/*drug therapy
Nitriles/*therapeutic use
Triazoles/*therapeutic use
Anastrozole ; Clinical Trials as Topic ; Disease Progression ; Female ; Humans
Opinia redakcyjna
Tytuł:
Aromatase inhibitors for the endocrine adjuvant treatment of breast cancer.
Autorzy:
Ravdin P; Department of Medical Oncology, University of Texas Health Science Center, San Antonio, TX 98284-7884, USA.
Pokaż więcej
Źródło:
Lancet (London, England) [Lancet] 2002 Jun 22; Vol. 359 (9324), pp. 2126-7.
Typ publikacji:
Journal Article; Comment
MeSH Terms:
Aromatase Inhibitors*
Anticarcinogenic Agents/*therapeutic use
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Breast Neoplasms/*drug therapy
Enzyme Inhibitors/*therapeutic use
Nitriles/*therapeutic use
Tamoxifen/*therapeutic use
Triazoles/*therapeutic use
Anastrozole ; Breast Neoplasms/prevention & control ; Chemotherapy, Adjuvant ; Female ; Humans ; Middle Aged ; Neoplasm Recurrence, Local/prevention & control ; Postmenopause
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies